GALT - Galectin Therapeutics Stock Trading

Galectin Therapeutics Inc.(NASDAQ: GALT) stock trading, description, contact, officers and directors.

About Galectin Therapeutics Inc.

Galectin is a clinical development stage biopharmaceutical company based in Norcross, Georgia, that is targeting fibrotic diseases and cancer with novel galectin inhibitor compounds. Galectins are a class of proteins made by many cells in the body and are important therapeutic targets because they are the mediators of fundamental biologic mechanisms in pathological processes. Galectin Therapeutics leverages its extensive scientific knowledge of galectins to advance their discovery program including research and discovery of new compounds. Through a relationship with a world class research program at the University of Georgia, the Company focuses on the discovery of new carbohydrate molecules that can be used in the therapy of diseases where galectin proteins play a major role including cancer and inflammatory and fibrotic disorders.

Stock Information

Galectin Therapeutics Inc. Company Name:

GALT Stock Symbol:

NASDAQ Market:

Galectin Therapeutics Inc. Website:

GALT - Galectin Therapeutics Stock Trading

GALT GALT Quote GALT Short GALT News GALT Articles GALT Message Board

Get GALT Alerts

News, Short Squeeze, Breakout and More Instantly...

GALT - Galectin Therapeutics to Present at 4th Global NASH Congress

NORCROSS, Ga., April 27, 2021 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that Pol F. Boudes, M.D., Chief Medical Officer , will present the belapectin program at the 4...
GALT - World-Renowned Neurosurgeon Dr. Ben Carson, Sr. Joins Galectin Therapeutics as Special Consultant to Accelerate and Enhance Development of Company's Galectin-3 Inhibitor, Belapectin

NORCROSS, Ga., April 19, 2021 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced it has engaged Dr. Ben Carson, Sr., a world-renowned neurosurgeon and the 17th Secretary of the U.S. Depar...
GALT - Today's Biggest Pre-Market Movers: 10 Top Gainers and Losers on Wednesday Morning

InvestorPlace - Stock Market News, Stock Advice & Trading Tips The early bird gets the worm and that’s exactly what you should be planning for today! We’re at the midpoint of the week and there’s plenty of reason for investors to keep an eye on pre-market movers to...